News Channels

12 Apr 2019 FDA Approves Expanded Monotherapy Label for Merck’s KEYTRUDA® (pembrolizumab)
12 Apr 2019 Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH
11 Apr 2019 Gilead Presents New Data in Nonalcoholic Steatohepatitis (NASH) at the International Liver Congress™ 2019
11 Apr 2019 Intas Pharmaceuticals Launches its Trastuzumab Biosimilar, Eleftha® - Further Bringing Down the Treatment Cost by 65%
11 Apr 2019 Lynparza approved in EU for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer
10 Apr 2019 Sound Biologics Announces FDA Allowance of its IND Application for PSB205, an Anti-PD-1/CTLA-4 MabPair, in Relapsed and Refractory Solid Tumors
10 Apr 2019 FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
10 Apr 2019 NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
10 Apr 2019 Synaffix Announces License Agreement Worth up to $125 Million with Leading Chinese ADC Developer, Shanghai Miracogen
09 Apr 2019 BioAtla and BeiGene Form Worldwide Collaboration to Develop and Commercialize Novel Conditionally Active Biologic CTLA-4 Therapy
09 Apr 2019 PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
09 Apr 2019 Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes
09 Apr 2019 Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for Hearing Restoration
09 Apr 2019 Generium Launches First Biosimilar of Eculizumab; Becomes Fifth Marketed Product Using Selexis SUREtechnology Platform
09 Apr 2019 Zogenix Receives Refusal to File Letter from U.S. Food and Drug Administration for FINTEPLA® New Drug Application
09 Apr 2019 Translate Bio Presents Preclinical Data Supporting MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
09 Apr 2019 Enesi Pharma and University of Oxford Collaborate to Target Plague With a Novel ImplaVax®-enabled Adenovirus-based Solid Dose Vaccine
09 Apr 2019 Poxel and Sumitomo Dainippon Pharma Announce Positive Top-Line Results for Imeglimin Phase 3 Trial (TIMES 1) in Japan for the Treatment of Type 2 Diabetes
09 Apr 2019 PIXUVRI® (pixantrone) Receives Positive CHMP Opinion to Convert Conditional Approval into Standard Marketing Authorization in Patients with Aggressive non-Hodgkin B-cell Lymphoma
09 Apr 2019 LEO Pharma and Elektrofi Expand Partnership to Co-Develop New Antibodies with the Aim of Achieving Improvements in Drug Delivery within Dermatology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up